LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.65 | 21.74 | 3256 | 3754 | 0.8673 | 0.9621 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.65 | 21.74 | 3394 | 3754 | 0.9041 | 0.9730 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.65 | 21.74 | 86 | 3754 | 0.0229 | 0.2033 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.65 | 21.74 | 4779 | 3754 | 1.2730 | 1.0660 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.62 | 21.74 | 3663 | 4150 | 0.8825 | 0.9673 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.62 | 21.74 | 3749 | 4150 | 0.9032 | 0.9733 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.62 | 21.74 | 34 | 4150 | 0.0082 | 0.0608 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.62 | 21.74 | 5176 | 4150 | 1.2470 | 1.0591 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.59 | 21.74 | 4051 | 4492 | 0.9018 | 0.9733 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.59 | 21.74 | 4198 | 4492 | 0.9345 | 0.9825 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.59 | 21.74 | 21 | 4492 | 0.0047 | -0.0045 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.59 | 21.74 | 5531 | 4492 | 1.2313 | 1.0548 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.56 | 21.74 | 4376 | 4838 | 0.9044 | 0.9744 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.56 | 21.74 | 4560 | 4838 | 0.9424 | 0.9848 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.56 | 21.74 | 45 | 4838 | 0.0093 | 0.0978 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.56 | 21.74 | 5931 | 4838 | 1.2257 | 1.0529 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.53 | 21.74 | 4644 | 5150 | 0.9016 | 0.9739 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.53 | 21.74 | 4972 | 5150 | 0.9653 | 0.9911 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.53 | 21.74 | 64 | 5150 | 0.0124 | 0.1467 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.53 | 21.74 | 6469 | 5150 | 1.2559 | 1.0586 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.50 | 21.74 | 4746 | 5425 | 0.8747 | 0.9667 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.50 | 21.74 | 5256 | 5425 | 0.9687 | 0.9920 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.50 | 21.74 | 32 | 5425 | 0.0059 | 0.0497 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.50 | 21.74 | 6979 | 5425 | 1.2862 | 1.0642 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.48 | 21.74 | 4734 | 5768 | 0.8206 | 0.9515 | MN20160310_N01 | D09 |